KIR3DL1 and hepatocellular carcinoma: Furthermore, the proportion of patients having KIR3DL1 with at least one HLA-Bw4 allele (Bw4–80I or Bw4–80T) was lower in patients with NHL than in HCC and MC patients (55.4% versus, 69.8% and 75.7%, p = 0.05 and p = 0.01, respectively).